Skip to content

CLINICAL STUDY TO EVALUATE EFFECT OF KASISADI CHURNA WITHBMADHU IN VAGINAL CANDIDIASIS( WHITE DISCHARGE).

OPEN LABELLED RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE EFFECT AFTER LOCAL APPLICATION OF KASISADI CHURNA WITH MADHU IN KAPHAJ YONIVYAPAD WITH SPECIAL REFERANCE TO VAGINAL CANDIDIASIS. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084300
Enrollment
30
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

None listed

Sponsors

Dr Vaishnavi Ramdas Dhole
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subject diagnosed as vaginal candidiasis (kaphaj yonivyapad) as per diagnostic criteria. 2) Subjects in between 18-35yrs. 3) Sexually active women with due consent for study.

Exclusion criteria

Exclusion criteria: 1. Pregnant women. 2. Patients with any STD s, severe systemic illness like immune compromised, uncontrolled diabetes. 3. Any other pathology of reproductive organ like cervical polyp, fibroid. 4. Cases not willing to undergo this treatment. 5. Patients using contraceptives like CU-T, OC pills, Steroid and antibiotics drugs.

Design outcomes

Primary

MeasureTime frame
OPEN LABELLED RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE EFFECT AFTER LOCAL APPLICATION OF KASISADI CHURNA WITH MADHU IN KAPHAJ YONIVYAPAD WITH SPECIAL REFERANCE TO VAGINAL CANDIDIASIS. Timepoint: 5 Days

Secondary

MeasureTime frame
no anyTimepoint: no

Countries

India

Contacts

Public ContactDr gopal Jadhav

Government ayurved college vazirabad Nanded Maharashtra

vaishnavidhole1999@gmail.com09284894460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026